Antares Pharma, Inc. (ATRS)

CapEx to Revenue

0.19%

Quarterly · Period ending:

ATRS logo

ATRS CapEx to Revenue

Latest reported0.19%
ATRS Quarterly CapEx/Revenue (0.00% → 0.19%)
High-resolution chart · PNG

ATRS capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0.1949%
3.4004%
5.1939%
2.8303%
2.8135%
15.2312%
13.6215%
5.5676%
1.9378%
2.8436%
0.4955%
2.5076%
1.6791%
1.7427%
1.1809%
2.0054%
0.5589%
2.1765%
2.4995%
1.1206%
3.6299%
4.3972%
13.2671%
6.4988%
14.6078%
5.6362%
8.7481%
15.4943%
33.7474%
28.1051%
32.2767%
15.8051%
3.2863%
16.5116%
8.7624%
18.7718%
17.7045%
14.3982%
39.7037%
4.968%
3.3077%
3.6924%
2.4585%
3.9686%
4.0471%
2.0782%
1.8016%
1.7552%
1.0113%
2.6572%
1.5669%
3.3329%
1.5601%
8.2319%
51.2768%
0.9563%
61.554%
5.5554%
6.1037%
1.8797%
0.8195%
3.3363%
1.4019%
7.2121%
6.0673%
3.1524%
2.2726%
2.6914%
11.4273%
13.1442%
2.9912%
14.0136%
1.2059%
0%
0%
0%
0.1275%
0.6007%
2.1223%
4.8511%
10.2293%
2.7956%
26.8531%
15.2586%
10.4295%
171.5401%
7.2407%
4.1589%
3.9717%
22.7314%
20%
0%
0%
10.2643%
28.5714%
12.5%
33.3333%
27.7039%
50%
22.2222%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.